Join Growin Stock Community!

Establishment labs holdings inc.ESTA.US Overview

US StockHealthcare
(No presentation for ESTA)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

ESTA AI Insights

ESTA Overall Performance

ESTA AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

ESTA Recent Performance

-4.34%

Establishment labs holdings inc.

0.05%

Avg of Sector

-0.31%

S&P500

ESTA PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

ESTA Key Information

ESTA Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

ESTA Profile

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Price of ESTA

ESTA FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

ESTA Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.76
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
10.83
PB Ratio
137.01
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
69.32%
Net Margin
-24.19%
Revenue Growth (YoY)
27.14%
Profit Growth (YoY)
33.58%
3-Year Revenue Growth
13.83%
3-Year Profit Growth
17.36%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.76
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
10.83
PB Ratio
137.01
Price-to-FCF
-
Gross Margin
69.32%
Net Margin
-24.19%
Revenue Growth (YoY)
27.14%
Profit Growth (YoY)
33.58%
3-Year Revenue Growth
13.83%
3-Year Profit Growth
17.36%
  • When is ESTA's latest earnings report released?

    The most recent financial report for Establishment labs holdings inc. (ESTA) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating ESTA's short-term business performance and financial health. For the latest updates on ESTA's earnings releases, visit this page regularly.

  • What is the operating profit of ESTA?

    According to the latest financial report, Establishment labs holdings inc. (ESTA) reported an Operating Profit of -3.93M with an Operating Margin of -6.08% this period, representing a growth of 78.95% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is ESTA's revenue growth?

    In the latest financial report, Establishment labs holdings inc. (ESTA) announced revenue of 64.62M, with a Year-Over-Year growth rate of 45.16%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does ESTA have?

    At the end of the period, Establishment labs holdings inc. (ESTA) held Total Cash and Cash Equivalents of 75.57M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does ESTA go with three margins increasing?

    In the latest report, Establishment labs holdings inc. (ESTA) did not achieve the “three margins increasing” benchmark, with a gross margin of 70.5%%, operating margin of -6.08%%, and net margin of -4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess ESTA's profit trajectory and future growth potential.

  • Is ESTA's EPS continuing to grow?

    According to the past four quarterly reports, Establishment labs holdings inc. (ESTA)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.08. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of ESTA?

    Establishment labs holdings inc. (ESTA)'s Free Cash Flow (FCF) for the period is -1.99M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 90.71% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of ESTA?

    The latest valuation data shows Establishment labs holdings inc. (ESTA) has a Price-To-Earnings (PE) ratio of -45.19 and a Price/Earnings-To-Growth (PEG) ratio of 2.69. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.